Ingenuity Licenses Pathway Analysis Software to Genizon BioSciences ... | GenomeWeb

NEW YORK, Oct. 25 (GenomeWeb News) - Ingenuity Systems will license its pathway analysis software to Genizon BioSciences, the companies announced today.

 

Under the agreement, Genizon will apply Ingenuity Pathways Analysis 3.0 to its lead programs studying Crohn's disease, psoriasis, asthma, baldness, and schizophrenia.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.